Dian Diagnostics Group Co.,Ltd.

SZSE:300244 Stock Report

Market Cap: CN¥6.9b

Dian Diagnostics GroupLtd Balance Sheet Health

Financial Health criteria checks 5/6

Dian Diagnostics GroupLtd has a total shareholder equity of CN¥9.5B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 39.9%. Its total assets and total liabilities are CN¥17.1B and CN¥7.6B respectively. Dian Diagnostics GroupLtd's EBIT is CN¥406.9M making its interest coverage ratio 2.4. It has cash and short-term investments of CN¥1.7B.

Key information

39.9%

Debt to equity ratio

CN¥3.78b

Debt

Interest coverage ratio2.4x
CashCN¥1.73b
EquityCN¥9.48b
Total liabilitiesCN¥7.60b
Total assetsCN¥17.08b

Recent financial health updates

Recent updates

Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly

Dec 12
Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly

Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry

Oct 04
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry

Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough

Aug 20
Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough

Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)

Jul 12
Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)

Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year

Jun 10
Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year

Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly

May 24
Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly

Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Apr 30
Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)

Apr 22
Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)

Financial Position Analysis

Short Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its short term liabilities (CN¥4.9B).

Long Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its long term liabilities (CN¥2.7B).


Debt to Equity History and Analysis

Debt Level: 300244's net debt to equity ratio (21.7%) is considered satisfactory.

Reducing Debt: 300244's debt to equity ratio has reduced from 63.2% to 39.9% over the past 5 years.

Debt Coverage: 300244's debt is well covered by operating cash flow (42.6%).

Interest Coverage: 300244's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 16:04
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dian Diagnostics Group Co.,Ltd. is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Yolanda YinChina Galaxy International Securities (Hong Kong)
Pei ChengChina Galaxy Securities Co., Ltd.